CD8A and malignant colon neoplasm: Consequently, we suggest boosting IL-12 expression as a strategy to amplify the infiltration ratio of GZMA+IFN-γ+CD8+TILs, potentially elevating the sensitivity of colon cancer cells to both immunotherapy and chemotherapy, thus intensifying antitumor efficacy.